Skip to main
AZTA
AZTA logo

Azenta (AZTA) Stock Forecast & Price Target

Azenta (AZTA) Analyst Ratings

Based on 6 analyst ratings
Buy
Strong Buy 33%
Buy 33%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

Azenta Inc has demonstrated strong financial performance, highlighted by an adjusted EBITDA margin of 10.2%, which reflects a significant year-over-year increase of 560 basis points and exceeds consensus expectations. The company's adjusted gross margin of 47.6%, up 270 basis points year-over-year, indicates improved profitability driven by operational efficiencies and a favorable product mix. Additionally, positive growth in the Multiomics and Sample Management Solutions segments supports a bullish outlook for future revenue expansion and margin improvement.

Bears say

Azenta Inc. has provided FY25 guidance indicating lower growth expectations for both its Sample Management Solutions (SMS) and Multiomics segments, excluding B Medical from the forecast. Recent financial performance highlights a decline in revenue to $170 million, reflecting a 2% year-over-year decrease in constant currency organic growth, significantly down from the previous quarter's 25% growth rate, along with a notable 11% decline in the Sanger segment year-over-year. Increased competition in Multiomics and slower traction in SMS suggest potential for margin contraction and a risk of slowing or negative earnings per share (EPS) growth, contributing to a negative outlook for the company's financial future.

Azenta (AZTA) has been analyzed by 6 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 33% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Azenta and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Azenta (AZTA) Forecast

Analysts have given Azenta (AZTA) a Buy based on their latest research and market trends.

According to 6 analysts, Azenta (AZTA) has a Buy consensus rating as of Jun 16, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $60.83, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $60.83, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Azenta (AZTA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.